<H1>Chapter DOI: 10.1208/aapsj070250<br/>Cited-By Count: 8</H1><table border="1" width="30%"><tr><td>Total References</td><td>27</td></tr><tr><td>Springer references</td><td>0</td></tr><tr><td>Non Springer references</td><td>27</td></tr><tr><td>BibStructured Count</td><td width="10%">27</td></tr><tr><td>BibUnstructured Count</td><td width="10%">0</td></tr><tr><td>DOI already available in SpringerLink</td><td>20</td></tr><tr><td>Additional DOI extracted from CrossRef-Meta</td><td>2</td></tr><tr><td>Additional DOI extracted from CrossRef-Web</td><td>0</td></tr><tr><td>Additional DOI extracted from ResearchGate-Web</td><td>0</td></tr><tr><td>Additional DOI extracted from SpringerLink-FUZZY-Search</td><td>0</td></tr><tr><td>Spelling Mistakes</td><td>NULL</td></tr><tr><td>Wrong DOI</td><td>0</td></tr><tr><td>ISBN</td><td>NULL</td></tr><tr><td>Web Link</td><td>NULL</td></tr><tr><td>DOI Obtained For Springer Published</td><td>0</td></tr><tr><td>DOI Obtained For Non Springer</td><td>2</td></tr><tr><td>DOI Obtained From Structured Ref</td><td>2</td></tr><tr><td>DOI Obtained From Unstructured Ref</td><td>0</td></tr><tr><td>Valid DOI Enriched</td><td>0</td></tr></table></br></br><table border="1">
<tr><th>Bib. ID</th><th>Ref. Type</th><th>References</th><th>DOI</th><th>Suspected DOI</th><th>DOI Source</th><th>Validated Elements</th><th>Validation Source</th></tr><tr><td>CR1</td><td>BibBook</td><td>Di Marzo V.<Emphasis Type="Italic">Cannabinoids</Emphasis>. New York: Plenum Publishers, 2004.</td><td>&nbsp;</td><td><a href=http://dx.doi.org/10.1002/9781118451281>10.1002/9781118451281</a></td><td><b>CrossRef-Meta</b></td>
<td>BookTitle</td><td>CrossRef</td></tr><tr><td>CR2</td><td>BibArticle</td><td>Di Marzo V, Bisogno T, De Petrocellis L, Melck D, Martin BR. Cannabimimetic fatty acid derivatives: the anandamide family and other &#8220;endocannabinoids&#8221;.<Emphasis Type="Italic">Curr Med Chem.</Emphasis> 1996;6:721&#8211;744.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR3</td><td>BibBook</td><td>Pertwee RG, ed.<Emphasis Type="Italic">Cannabinoid Receptors</Emphasis>. London, UK: Academic Press Ltd; 1995.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR4</td><td>BibArticle</td><td>Pertwee RG. Pharmacology of cannabinoid CB<Subscript>1</Subscript> and CB<Subscript>2</Subscript> receptors.<Emphasis Type="Italic">Pharmacol Ther.</Emphasis> 1997;74:129&#8211;180.</td><td><a href=http://dx.doi.org/10.1016/S0163-7258(97)82001-3>10.1016/S0163-7258(97)82001-3</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR5</td><td>BibArticle</td><td>Pertwee RG. Pharmacology of cannabinoid receptor ligands.<Emphasis Type="Italic">Curr Med Chem.</Emphasis> 1999;6:635&#8211;664.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR6</td><td>BibArticle</td><td>Devane WA III, Dysarz FA, III, Johnson MR, Melvin LS, Howlett AC. Determination and characterization of a cannabinoid, receptor in rat brain.<Emphasis Type="Italic">Mol Pharmacol.</Emphasis> 1988;34:605&#8211;613.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR7</td><td>BibArticle</td><td>Munro S, Thomas KL, Abu-Shaar M. Molecular characterization of a peripheral receptor for cannabinoids.<Emphasis Type="Italic">Nature</Emphasis>. 1993;365:61&#8211;65.</td><td><a href=http://dx.doi.org/10.1038/365061a0>10.1038/365061a0</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR8</td><td>BibArticle</td><td>Rinaldi-Carmona M, Barth F, Heaulme M, et al. SR141716A, a potent and selective antagonist of the brain cannabinoid receptor.<Emphasis Type="Italic">FEBS Lett.</Emphasis> 1994;350:240&#8211;244.</td><td><a href=http://dx.doi.org/10.1016/0014-5793(94)00773-X>10.1016/0014-5793(94)00773-X</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR9</td><td>BibArticle</td><td>Rinaldi-Carmona M, Barth F, Millan J, et al. SR 144528, the first potent and selective antagonist of the CB2 cannabinoid receptor.<Emphasis Type="Italic">J Pharmacol Exp Ther.</Emphasis> 1998;284:644&#8211;650.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR10</td><td>BibArticle</td><td>Martin BR, Mechoulam R, Razdan RK. Discovery and characterization of endogenous cannabinoids.<Emphasis Type="Italic">Life Sci.</Emphasis> 1999;65:573&#8211;595.</td><td><a href=http://dx.doi.org/10.1016/S0024-3205(99)00281-7>10.1016/S0024-3205(99)00281-7</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR11</td><td>BibArticle</td><td>Hanus L, Abu-Lafi S, Fride E, et al. 2-Arachidonylglyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor.<Emphasis Type="Italic">Proc. Natl Acad Sci USA</Emphasis>. 2001;98:3662&#8211;3665.</td><td><a href=http://dx.doi.org/10.1073/pnas.061029898>10.1073/pnas.061029898</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR12</td><td>BibArticle</td><td>Porter AC, Sauer JM, Knierman MD, et al. Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor.<Emphasis Type="Italic">J Pharmacol Exp Ther.</Emphasis> 2002;301:1020&#8211;1024.</td><td><a href=http://dx.doi.org/10.1124/jpet.301.3.1020>10.1124/jpet.301.3.1020</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR13</td><td>BibArticle</td><td>Huang SM, Bisogno T, Trevisani M. An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors.<Emphasis Type="Italic">Proc Natl Acad Sci USA</Emphasis> 2002;99:8400&#8211;8405.</td><td><a href=http://dx.doi.org/10.1073/pnas.122196999>10.1073/pnas.122196999</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR14</td><td>BibArticle</td><td>Sheskin T, Hanus L, Slager J, Vogel Z, Mechoulam R. Structural requirements for binding of anandamide type compounds to the brain cannabinoid, receptor.<Emphasis Type="Italic">J Med Chem.</Emphasis> 1997;40:659&#8211;667.</td><td><a href=http://dx.doi.org/10.1021/jm960752x>10.1021/jm960752x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR15</td><td>BibArticle</td><td>Khanolkar AD, Makriyannis A. Structure-activity relationships of anandamide, an endogenous cannabinoid ligand.<Emphasis Type="Italic">Life Sci.</Emphasis> 1999;65:607&#8211;616.</td><td><a href=http://dx.doi.org/10.1016/S0024-3205(99)00283-0>10.1016/S0024-3205(99)00283-0</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR16</td><td>BibArticle</td><td>Razdan RK, Mahadevan A. Recent advances in the synthesis of endocannabinoid related ligands.<Emphasis Type="Italic">Chem Phys Lipids</Emphasis>. 2002;121:21&#8211;33.</td><td><a href=http://dx.doi.org/10.1016/S0009-3084(02)00142-1>10.1016/S0009-3084(02)00142-1</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR17</td><td>BibArticle</td><td>Altundas R, Mahadevan A, Razdan RK. A synthetic route to anandamide analogues canying a substituent at the teminal carbon and an acetylene group in the end pentyl chain.<Emphasis Type="Italic">Tetrahedron Lett</Emphasis>. 2004;45:5449&#8211;5451.</td><td><a href=http://dx.doi.org/10.1016/j.tetlet.2004.05.071>10.1016/j.tetlet.2004.05.071</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR18</td><td>BibArticle</td><td>Qi L, Meijler MM, Lee S-H, Sun C, Janda KD. Solid-phase synthesis of anandamide analogues.<Emphasis Type="Italic">Org Lett.</Emphasis> 2004;6:1673&#8211;1675.</td><td><a href=http://dx.doi.org/10.1021/ol049474j>10.1021/ol049474j</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR19</td><td>BibArticle</td><td>Parkkari T, Savinainen JR, Rauhala AL, et al. Synthesis and CB1 receptor activities of novel arachidonyl alcohol derivatives.<Emphasis Type="Italic">Bioorg Med Chem Lett.</Emphasis> 2004;14:3231&#8211;3234.</td><td><a href=http://dx.doi.org/10.1016/j.bmcl.2004.03.093>10.1016/j.bmcl.2004.03.093</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR20</td><td>BibArticle</td><td>Fangour SE, Balas L, Rossi J-C, et al. Hemisynthesis and preliminary evaluation of novel endocannabinoid analogues.<Emphasis Type="Italic">Bioorg Med Chem Lett</Emphasis>. 2003;13:1977&#8211;1980.</td><td>&nbsp;</td><td><a href=http://dx.doi.org/10.1016/S0960-894X(03)00348-2>10.1016/S0960-894X(03)00348-2</a></td><td><b>CrossRef-Meta</b></td>
<td>VolumeID, Author_FamilyName_2, FirstPage, ArticleTitle, Year</td><td>CrossRef</td></tr><tr><td>CR21</td><td>BibArticle</td><td>Juntunen J, Vepsalainen J, Niemi R, Laine K, Jarvinen T. Synthesis, in vitro evaluation, and intraocular pressure effects of water-soluble prodrugs of endocannabinoid noladin ether.<Emphasis Type="Italic">J Med Chem</Emphasis>. 2003;46:5083&#8211;5086.</td><td><a href=http://dx.doi.org/10.1021/jm030877j>10.1021/jm030877j</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR22</td><td>BibArticle</td><td>Tarzia G, Duranti A, Tontini A, et al. Design, synthesis, and structure-activity relationships of alkylcarbamic acid aryl esters, a new class of fatty acid amide hydrolase inhibitors.<Emphasis Type="Italic">J Med Chem</Emphasis>. 2003;46:2352&#8211;2360.</td><td><a href=http://dx.doi.org/10.1021/jm021119g>10.1021/jm021119g</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR23</td><td>BibArticle</td><td>Mor M, Rivara S, Lodola A, et al. Cyclohexylcarbamic acid 3&#8242;- or 4&#8242;-substituted biphenyl-3-yl esters as fatty acid amide hydrolase inhibitors: synthesis, quantitative structure-activity relationships, and molecular modeling studies.<Emphasis Type="Italic">J Med Chem.</Emphasis> 2004;47:4998&#8211;5008.</td><td><a href=http://dx.doi.org/10.1021/jm031140x>10.1021/jm031140x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR24</td><td>BibArticle</td><td>Segall Y, Quistad GB, Nomura DK, Casida JE. Arachidonylsulfonyl derivatives as cannabinoid CB1 receptor and fatty acid amide hydrolase inhibitors.<Emphasis Type="Italic">Bioorg Med Chem Lett.</Emphasis> 2003;13:3301&#8211;3303.</td><td><a href=http://dx.doi.org/10.1016/S0960-894X(03)00721-2>10.1016/S0960-894X(03)00721-2</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR25</td><td>BibArticle</td><td>Lopez-Rodriguez ML, Ortega-Gutierrez S. The anandamide degradation system as potential targets for the treatment of central nervous system related disorders.<Emphasis Type="Italic">Curr Med Chem Cent Nerv Syst Agents</Emphasis>. 2004;4:155&#8211;160.</td><td><a href=http://dx.doi.org/10.2174/1568015043356959>10.2174/1568015043356959</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR26</td><td>BibArticle</td><td>Di Marzo V, Ligresti A, Morera E, Nalli M, Ortar G. The anandamide membrane transporter. Structure-activity relationships of anadamide and oleoylethanolamine analogs with phenyl rings in the polar head group region.<Emphasis Type="Italic">Bioorg Med Chem.</Emphasis> 2004;12:5161&#8211;5169.</td><td><a href=http://dx.doi.org/10.1016/j.bmc.2004.07.026>10.1016/j.bmc.2004.07.026</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR27</td><td>BibArticle</td><td>Lopez-Rodriguez ML, Viso A, Ortega-Gutierrez S, et al. Design, synthesis, and biological evaluation of new inhibitors of the endocannabinoid uptake: comparison with effects on fatty acid amidohydrolase.<Emphasis Type="Italic">J Med Chem.</Emphasis> 2003;46:1512&#8211;1522.</td><td><a href=http://dx.doi.org/10.1021/jm0210818>10.1021/jm0210818</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr></table>